Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anna Płaszczyńska"'
Publikováno v:
Przegląd Dermatologiczny, Vol 109, Iss 5, Pp 368-376 (2023)
Externí odkaz:
https://doaj.org/article/f3971878751f4b0ebfa519bc4127773a
Publikováno v:
Przegląd Dermatologiczny, Vol 109, Iss 4, Pp 299-309 (2023)
Externí odkaz:
https://doaj.org/article/6d61893b6f9d4ff3af394a413d459e6b
Publikováno v:
Przegląd Dermatologiczny, Vol 109, Iss 2, Pp 138-141 (2022)
Acquired lymphangioma, also called acquired cutaneous lymphangiectasia or secondary lymphangioma, is a relatively rare and benign tumour consisting of dilated superficial lymphatic vessels. We present 50-year-old patient diagnosed with acquired lymph
Externí odkaz:
https://doaj.org/article/e311f34e1aca4c539339773d5228fbe3
Autor:
Aleksandra Rosiak-Buller, Anna Płaszczyńska, Martyna Sławińska, Joanna Lakomy, Michał Sobjanek
Publikováno v:
Przegląd Dermatologiczny, Vol 108, Iss 4, Pp 290-298 (2021)
Externí odkaz:
https://doaj.org/article/9efd2d35fc0040aab1c9037e1536330f
Autor:
Anna Płaszczyńska, Martyna Sławińska, Tomasz Nowicki, Grzegorz Śmigielski, Roman Nowicki, Michał Sobjanek
Publikováno v:
Przegląd Dermatologiczny, Vol 108, Iss 3, Pp 227-231 (2021)
Externí odkaz:
https://doaj.org/article/777fb2b97d734f7a830efa10802a1a0e
Publikováno v:
Przegląd Dermatologiczny, Vol 108, Iss 5, Pp 426-428 (2022)
Externí odkaz:
https://doaj.org/article/542d6e68870843b699cd2e77c476a3a0
Publikováno v:
Dermatology Review. 109:368-376
Publikováno v:
International journal of dermatologyReferences. 61(9)
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
A 28-year-old woman (phototype III), with hypothyroidism (treated by levothyroxine 50 µg), presented to a dermatology outpatient clinic due to viral warts (Figure 1a). The first lesion appeared two years before on the right thumb. Since that time th
Autor:
Anna Płaszczyńska, Robert Skibiński, Martyna Sławińska, Wojciech Biernat, Aleksandra Lesiak, Roman Nowicki, Michal Sobjanek
Publikováno v:
Postepy dermatologii i alergologii. 39(1)
Basal cell carcinoma (BCC) is the most common malignant neoplasm of the skin. Management of patients with recurrent BCC remains a current clinical issue. Data concerning BCC recurrence rates as well as characteristics of this group of patients in the